高密度脂蛋白与2型糖尿病：它们关系中的新观点。
High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship.
作者信息
Kostapanos Michael S, Elisaf Moses S
机构信息
Michael S Kostapanos, Moses S Elisaf, Department of Internal Medicine, School of Medicine, University of Ioannina, 45110 Ioannina, Greece.
出版信息
World J Exp Med. 2014 Feb 20;4(1):1-6. doi: 10.5493/wjem.v4.i1.1.
Abstract
Patients with type 2 diabetes mellitus (T2DM) frequently exhibit macrovascular complications of atherosclerotic cardiovascular (CV) disease. High density lipoproteins (HDL) are protective against atherosclerosis. Low levels of HDL cholesterol (HDL-C) independently contribute to CV risk. Patients with T2DM not only exhibit low HDL-C, but also dysfunctional HDL. Furthermore, low concentration of HDL may increase the risk for the development of T2DM through a decreased β cell survival and secretory function. In this paper, we discuss emerging concepts in the relationship of T2DM with HDL.
摘要
2型糖尿病（T2DM）患者常表现出动脉粥样硬化性心血管（CV）疾病的大血管并发症。高密度脂蛋白（HDL）具有抗动脉粥样硬化作用。低水平的高密度脂蛋白胆固醇（HDL-C）独立增加心血管疾病风险。T2DM患者不仅HDL-C水平低，而且HDL功能异常。此外，HDL浓度降低可能通过降低β细胞存活和分泌功能增加T2DM发生风险。在本文中，我们讨论了T2DM与HDL关系中的新观点。
相似文献
1
High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship.高密度脂蛋白与2型糖尿病：它们关系中的新观点。
World J Exp Med. 2014 Feb 20;4(1):1-6. doi: 10.5493/wjem.v4.i1.1.
2
Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.载脂蛋白 B 和非高密度脂蛋白胆固醇在 2 型糖尿病且低密度脂蛋白胆固醇控制良好的个体中显示出高致动脉粥样硬化性。
Lipids Health Dis. 2020 Jun 6;19(1):127. doi: 10.1186/s12944-020-01292-w.
3
The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation.HDL 的抗炎功能在 2 型糖尿病中受损：高血糖、对氧磷酶-1 和低度炎症的作用。
Cardiovasc Diabetol. 2017 Oct 12;16(1):132. doi: 10.1186/s12933-017-0613-8.
4
Size, density and cholesterol load of HDL predict microangiopathy, coronary artery disease and β-cell function in men with T2DM.高密度脂蛋白（HDL）的大小、密度和胆固醇负荷可预测2型糖尿病男性患者的微血管病变、冠状动脉疾病和β细胞功能。
Diabetes Metab Syndr. 2017 Apr-Jun;11(2):125-131. doi: 10.1016/j.dsx.2016.08.029. Epub 2016 Sep 1.
5
Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.2型糖尿病患者中，大颗粒极低密度脂蛋白（VLDL）和小颗粒低密度脂蛋白（LDL）增加与胆红素降低有关。
Clin Biochem. 2014 Nov;47(16-17):170-5. doi: 10.1016/j.clinbiochem.2014.08.008. Epub 2014 Aug 20.
6
Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects.在2型糖尿病患者和非糖尿病患者中，血清对氧磷酶-1活性与高密度脂蛋白（HDL）颗粒浓度及大HDL颗粒的关系，比与HDL胆固醇的关系更为密切。
Clin Biochem. 2014 Aug;47(12):1022-7. doi: 10.1016/j.clinbiochem.2014.04.013. Epub 2014 Apr 21.
7
Genetic basis of dyslipidemia in disease precipitation of coronary artery disease (CAD) associated type 2 diabetes mellitus (T2DM).冠状动脉疾病（CAD）合并2型糖尿病（T2DM）疾病发生中血脂异常的遗传基础。
Diabetes Metab Res Rev. 2015 Oct;31(7):663-71. doi: 10.1002/dmrr.2630. Epub 2015 Mar 5.
8
Pre-β-HDL formation relates to high-normal free thyroxine in type 2 diabetes mellitus.前β-高密度脂蛋白的形成与2型糖尿病患者游离甲状腺素处于正常高值有关。
Clin Biochem. 2016 Jan;49(1-2):41-6. doi: 10.1016/j.clinbiochem.2015.08.024. Epub 2015 Aug 28.
9
HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus.高密度脂蛋白胆固醇和低密度脂蛋白胆固醇对 2 型糖尿病患者的胰岛β细胞功能有显著影响。
Curr Opin Lipidol. 2010 Jun;21(3):178-85. doi: 10.1097/MOL.0b013e328339387b.
10
Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.脂蛋白、胰岛素抵抗与瑞舒伐他汀与 2 型糖尿病发病风险的相关性：一项随机临床试验的二次分析。
JAMA Cardiol. 2016 May 1;1(2):136-45. doi: 10.1001/jamacardio.2016.0096.
引用本文的文献
1
Assessment of common risk factors of diabetes and chronic kidney disease: a Mendelian randomization study.评估糖尿病和慢性肾脏病的常见危险因素：一项孟德尔随机研究。
Front Endocrinol (Lausanne). 2023 Sep 13;14:1265719. doi: 10.3389/fendo.2023.1265719. eCollection 2023.
2
Dietary Iron Restriction Improves Muscle Function, Dyslipidemia, and Decreased Muscle Oxidative Stress in Streptozotocin-Induced Diabetic Rats.饮食铁限制改善链脲佐菌素诱导的糖尿病大鼠的肌肉功能、血脂异常并减轻肌肉氧化应激
Antioxidants (Basel). 2022 Apr 7;11(4):731. doi: 10.3390/antiox11040731.
3
Deep Sea Water-Dissolved Organic Matter Intake Improves Hyperlipidemia and Inhibits Thrombus Formation and Vascular Inflammation in High-Fat Diet Hamsters.摄入深海水中溶解的有机物可改善高脂饮食仓鼠的高脂血症，抑制血栓形成和血管炎症。
Life (Basel). 2022 Jan 7;12(1):82. doi: 10.3390/life12010082.
4
Serum paraoxonase 1 activity in patients with iron deficiency anemia.缺铁性贫血患者的血清对氧磷酶1活性
Arch Med Sci. 2016 Aug 1;12(4):697-703. doi: 10.5114/aoms.2015.48730. Epub 2016 Jul 1.
5
Emerging risk biomarkers in cardiovascular diseases and disorders.心血管疾病和病症中新出现的风险生物标志物。
J Lipids. 2015;2015:971453. doi: 10.1155/2015/971453. Epub 2015 Apr 8.
本文引用的文献
1
Editorial: reducing cardiovascular risk: is low-density lipoprotein-cholesterol (LDL-C) lowering enough?社论：降低心血管风险：降低低密度脂蛋白胆固醇（LDL-C）是否足够？
Curr Vasc Pharmacol. 2012 Mar;10(2):173-7. doi: 10.2174/157016112799305085.
2
Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance.不同糖耐量人群高密度脂蛋白胆固醇水平与胰岛β细胞功能的相关性。
Acta Diabetol. 2013 Apr;50(2):277-81. doi: 10.1007/s00592-011-0339-0. Epub 2011 Oct 14.
3
The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release.抗氧化剂高密度脂蛋白相关的对氧磷酶-1（PON1）可减轻糖尿病的发展并刺激β细胞胰岛素释放。
Atherosclerosis. 2011 Dec;219(2):510-8. doi: 10.1016/j.atherosclerosis.2011.07.119. Epub 2011 Aug 4.
4
Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function.2 型糖尿病与三磷酸腺苷结合盒转运体 A1 基因表达、蛋白和功能降低有关。
PLoS One. 2011;6(7):e22142. doi: 10.1371/journal.pone.0022142. Epub 2011 Jul 27.
5
Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus.近年来 2 型糖尿病致动脉粥样硬化血脂异常治疗的进展。
Kidney Blood Press Res. 2011;34(4):209-17. doi: 10.1159/000326849. Epub 2011 Jun 21.
6
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary.“欧洲低密度脂蛋白（LDL）亚类专家小组”：关于LDL亚类的病理生理学、致动脉粥样硬化性及临床意义的声明：执行摘要
Curr Vasc Pharmacol. 2011 Sep;9(5):531-2. doi: 10.2174/157016111796642698.
7
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses."欧洲 LDL 亚类专家组": 关于 LDL 亚类的病理生理学、致动脉粥样硬化性和临床意义的声明。
Curr Vasc Pharmacol. 2011 Sep;9(5):533-71. doi: 10.2174/157016111796642661.
8
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management.富含甘油三酯的脂蛋白和心血管疾病高危患者的高密度脂蛋白胆固醇：管理的证据和指导。
Eur Heart J. 2011 Jun;32(11):1345-61. doi: 10.1093/eurheartj/ehr112. Epub 2011 Apr 29.
9
log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males.载脂蛋白 TG/高密度脂蛋白胆固醇与 2 型糖尿病男性的残余心血管代谢风险和胰岛β细胞功能丧失有关。
Cardiovasc Diabetol. 2010 Dec 14;9:88. doi: 10.1186/1475-2840-9-88.
10
Insulin suppresses HDL-mediated cholesterol efflux from macrophages through inhibition of neutral cholesteryl ester hydrolase and ATP-binding cassette transporter G1 expressions.胰岛素通过抑制中性胆固醇酯水解酶和 ATP 结合盒转运体 G1 的表达来抑制 HDL 介导的巨噬细胞胆固醇流出。
J Atheroscler Thromb. 2010 Nov 27;17(11):1183-9. doi: 10.5551/jat.4721. Epub 2010 Aug 20.
Zotero 插件